Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has reported a change in major shareholdings following a transaction on June 10, 2024, where Van Lanschot Kempen Investment Management NV’s stake has decreased from 7.76% to 5.09%, now owning 27,500,000 shares. The notification was completed on June 11, 2024, in Amsterdam. This shift in voting rights could signal significant movement for stakeholders in the UK-based company.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
